Rosalind group holds 9.9% of Delcath Systems
Delcath Systems, Inc. received an amended Schedule 13D/A from the Rosalind group detailing their equity stake and governance role.
Rhea-AI Filing Summary
Delcath Systems, Inc. received an amended Schedule 13D/A from the Rosalind group detailing their equity stake and governance role. Rosalind Advisors, Inc. reports beneficial ownership of 6,719,993 shares of common stock equivalents, representing 9.9% of the class after applying ownership blockers. These securities are primarily preferred stock and warrants that cannot be converted or exercised if ownership would exceed 9.99% for preferred shares or 4.99% for warrants. The percentages are based on 35,313,718 common shares outstanding as of October 27, 2025. Rosalind Master Fund L.P. reports 2,871,335 shares (4.4%), and Rosalind Opportunities Fund I L.P. reports 3,530,215 shares (4.9%). Steven Salamon and Gil Aharon, Canadian citizens and portfolio managers at Rosalind Advisors, also report 9.9% beneficial ownership each and serve as independent directors of Delcath, with board terms scheduled to run through the 2024 and 2025 annual meetings, respectively.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake does the Rosalind group report in Delcath Systems (DCTH)?
What are the ownership blockers affecting Rosalind’s Delcath preferred stock and warrants?
What stakes do Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P. hold in Delcath?
What roles do Steven Salamon and Gil Aharon have at Delcath Systems and Rosalind?
How is the 9.9% Delcath ownership percentage for the Rosalind group calculated?
AI-generated analysis. How Rhea-AI works. Not financial advice.